Testosterone Might Help Men With MS
HealthDay via Yahoo! News Thu, 06 Apr 2006 9:02 AM PDT
THURSDAY, April 6 (HealthDay News) -- Testosterone therapy may help improve cognitive function and slow brain atrophy in men with multiple sclerosis (MS), say researchers at the University of California, Los Angeles.

R.I. Gets Its First Medical Marijuana Bid AP via Yahoo! News Wed, 05 Apr 2006 4:50 PM PDT A multiple sclerosis patient who hopes to use marijuana to ease the painful symptoms of her disease became the first person to apply for state permission to legally use the drug under a new Rhode Island law Wednesday.

Study finds that high dose of MS drug works better Reuters via Yahoo! News Wed, 05 Apr 2006 2:18 PM PDT A high dose of Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone is more effective at limiting relapses and brain lesions than the standard dose, without more side effects, researchers said on Wednesday.

Men with MS may benefit from testosterone Reuters via Yahoo! News Wed, 05 Apr 2006 12:30 PM PDT Daily testosterone treatment of men with relapsing remitting multiple sclerosis (MS) -- the most common form of the disease in which symptoms wax and wane -- appears to be neuroprotective while improving their brain function. That's according to research presented this week at the American Academy of Neurology 58th Annual Meeting here.

Serono Seeks Approvals for New Rebif Formulation RedNova Thu, 06 Apr 2006 4:50 AM PDT Serono has submitted applications to both US and European regulators seeking marketing approval for a new more tolerable formulation of its multiple sclerosis drug, Rebif.

Men with MS may benefit from testosterone Reuters via Yahoo! Australia & NZ Health Wed, 05 Apr 2006 12:30 PM PDT SAN DIEGO (Reuters Health) - Daily testosterone treatment of men with relapsing remitting multiple sclerosis (MS) -- the most common form of the disease in which symptoms wax and wane -- appears to be neuroprotective while improving their brain function.

R.I. Gets Its First Medical Marijuana Bid ABC News Wed, 05 Apr 2006 5:23 PM PDT Rhode Island Gets Its First Application From a Patient for Medical Marijuana Under New Law

PharmaFrontiers to Present at BIO 2006 Business Forum RedNova Thu, 06 Apr 2006 7:55 AM PDT PharmaFrontiers Corp. (OTCBB:PFTR), a company i

The Problems Associated With Natalizumab, Coupled With the Withdrawal of the COX-2 Inhibitors in Late 2004, Have
RedNova Thu, 06 Apr 2006 4:54 AM PDT
Research and Markets (http://www.researchandmarkets.com/reports/c31740) has announced the addition of the Decision Resources report "Future of VLA-4 Antagonist Drugs and Implications for the Regulatory Process" to their offering.